Point72 Middle East Fze Adicet Bio, Inc. Transaction History

Point72 Middle East Fze

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.11 - $1.89 $7,512 - $12,791	-6,768 Reduced 59.42%	4,623 $8,000
Q3 2023 Nov 14, 2023	BUY	$1.37 - $3.4 $15,605 - $38,729	11,391 New	11,391 $15,000
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $15,003 - $25,087	-2,718 Reduced 22.12%	9,568 $55,000
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $94,847 - $261,323	12,286 New	12,286 $0

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.